$63.5 Million is the total value of Blackcrane Capital, LLC's 14 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 54.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WIX | Buy | WIX.COM LTD | $12,275,000 | +15.9% | 43,963 | +3.8% | 19.35% | -6.9% |
| PROF | Buy | PROFOUND MEDICAL CORP | $8,960,000 | +27.5% | 445,525 | +30.4% | 14.12% | +2.3% |
| RCEL | Buy | AVITA THERAPEUTICS INC | $8,289,000 | +44.6% | 418,194 | +35.6% | 13.06% | +16.1% |
| OTEX | Sell | OPEN TEXT CORP | $6,840,000 | -0.9% | 143,400 | -5.5% | 10.78% | -20.4% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $6,535,000 | – | 503,248 | +100.0% | 10.30% | – |
| NICE | Buy | NICE LTD - SPON ADRsponsored adr | $5,976,000 | -21.1% | 27,418 | +2.6% | 9.42% | -36.7% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $4,012,000 | -35.6% | 66,996 | -46.3% | 6.32% | -48.3% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $2,924,000 | +51.9% | 142,065 | +103.8% | 4.61% | +21.9% |
| BABA | New | ALIBABA GROUP HOLDING-SP ADRsponsored ads | $2,277,000 | – | 10,041 | +100.0% | 3.59% | – |
| TAK | Sell | TAIWAN SEMICONDUCTOR-SP ADRsponsored ads | $1,723,000 | +168.8% | 14,571 | -58.6% | 2.72% | +115.6% |
| HDB | New | HDFC BANK LTD-ADRsponsored ads | $1,630,000 | – | 20,978 | +100.0% | 2.57% | – |
| MSFT | Buy | MICROSOFT CORP | $1,138,000 | +12.3% | 4,826 | +5.9% | 1.79% | -9.8% |
| CLPT | New | CLEARPOINT NEURO INC | $872,000 | – | 41,266 | +100.0% | 1.37% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -11,499 | -100.0% | -2.16% | – |
| BHVN | Exit | BIOHAVEN PHARMACEUTICAL HOLD | $0 | – | -25,641 | -100.0% | -4.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.